The independent source for health policy research, polling, and news.
Showing 1 - 20 of 58
All but vanquished a quarter century ago, measles has taken root again in the U.S. Compared with prior administrations, President Donald Trump’s second term has been marred by misinformation and actions that stifle public health.
Experimental peptides are all the rage on longevity and “optimization” podcasts, but a lot of the chatter is misleading.
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
Hear from six pediatricians in measles hot spot Utah as the U.S. faces infection levels not seen in over three decades and prepares to lose its status as a country that eliminated the dangerous disease.
Measles has been spreading in Utah for nearly a year, straining hospitals, schools, and parents. The state’s outbreak provides a glimpse into a new era in America’s health, in which vaccine-preventable diseases become common again.
Travel bans and conflict have disrupted supply chains in the Democratic Republic of Congo, leaving health workers without Ebola tests and protective gear needed to contain the outbreak.
Post-mastectomy pain syndrome, or PMPS, is estimated to afflict tens of thousands of U.S. women each year. And yet it is not well understood and is inconsistently treated.
This week, the CDC began to publish long-awaited data that will reveal the extent of measles’ comeback. While applauding the science, researchers say the Trump administration has done little to contain the virus. “That we’re even talking about this is nuts,” one virologist said.
U.S. Public Health Service doctors and nurses are being deployed to Guantánamo and other detention centers as President Donald Trump escalates mass arrests in his campaign to curb immigration. Some have resigned in protest. Others offer a rare look into bleak conditions.
Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.
HIV physician John Weiser talks about why complying with President Donald Trump’s orders to erase transgender people is bad for science and society. And he notes that acquiescing didn’t spare the CDC from further harm.
Scientists are conducting genetic analyses to see if the measles outbreak that started in Texas is still spreading from state to state. It’s a contentious question, because the findings may determine whether America loses its measles-free status.
Through shrouded bureaucratic maneuvers, White House budget director Russell Vought and DOGE have quietly upended outbreak response, HIV treatment, and dementia care in communities across America.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The White House’s autism announcement exaggerates links to Tylenol, misleads on vaccines, and sets back the field by ignoring decades of research, scientists say.
A lack of faith in the soundness of the Centers for Disease Control and Prevention’s new direction has led states to explore enacting their own vaccine policies. A patchwork of divergent recommendations and requirements could result.
KFF Health News correspondent Amy Maxmen traces the political turmoil at the CDC under President Donald Trump.
Trump officials sowed fear and confusion among CDC scientists, slowing their response to the measles outbreak in West Texas. Cases surged and sparked new outbreaks across the U.S. and Mexico. Together, these linked outbreaks have sickened more than 4,500 and killed at least 16 in the U.S. and Mexico.
While Congress fails to stave off cuts to HIV care, community leaders in Mississippi and beyond race to limit the damage.
Researchers laid off in April were putting the finishing touches on in-depth HIV surveys that guide treatment and prevention. Some staff have been reinstated, but data remains in limbo.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF